(XYL) Xylem - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98419M1009
XYL: Pumps, Valves, Filtration, Treatment, Meters, Sensors, Software
Xylem Inc. (NYSE:XYL) is a global leader in water technology, addressing critical water challenges through innovative solutions. The company, rebranded from ITT WCO in 2011, operates across four key segments: Water Infrastructure, Applied Water, Measurement and Control Solutions, and Integrated Solutions and Services. Each segment is tailored to meet specific water management needs, from infrastructure to advanced digital solutions.
In Water Infrastructure, Xylem offers a comprehensive range of products designed to transport, treat, and treat water and wastewater. This includes pumps, filtration systems, and treatment equipment under brands like Flygt, Godwin, and Wedeco. These solutions are crucial for municipal and industrial applications, aiding in construction and environmental projects through mobile dewatering services.
The Applied Water segment focuses on providing pumps, valves, and heat exchangers for residential, commercial, and industrial applications. Brands like Goulds Water Technology and Bell & Gossett serve industries such as agriculture and HVAC, ensuring efficient water distribution and management in diverse settings.
Measurement and Control Solutions leverages smart technology to optimize water management. Products include smart meters and networked devices that enable remote monitoring and data analytics. This segment supports smart city initiatives and sustainability efforts, helping utilities and industries enhance water conservation and reduce waste.
Integrated Solutions and Services offers a suite of maintenance and digital services, including wastewater treatment and environmental remediation. This segment addresses the growing need for comprehensive water management solutions, aligning with global trends towards sustainability and environmental compliance.
From a financial perspective, Xylem Inc. has a market capitalization of $31.93 billion, with a P/E ratio of 36.01 and a forward P/E of 28.09. The price-to-book ratio is 3.00, and the price-to-sales ratio is 3.79. These metrics provide insights into the companys valuation and potential for investors seeking exposure to the water technology sector.
Xylem Inc. is headquartered in Washington, D.C., and can be found online at https://www.xylem.com. With a strong market position and commitment to innovation, Xylem plays a pivotal role in addressing global water challenges, making it a significant player in the industrial
Additional Sources for XYL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XYL Stock Overview
| Market Cap in USD | 29,926m |
| Sector | Industrials |
| Industry | Specialty Industrial Machinery |
| GiC Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception | 2011-10-13 |
XYL Stock Ratings
| Growth 5y | 32.5% |
| Fundamental | 51.2% |
| Dividend | 60.0% |
| Rel. Strength | -13.4 |
| Analysts | 4.05/5 |
| Fair Price Momentum | 113.50 USD |
| Fair Price DCF | 62.86 USD |
XYL Dividends
| Dividend Yield 12m | 1.19% |
| Yield on Cost 5y | 2.41% |
| Annual Growth 5y | 6.72% |
| Payout Consistency | 100.0% |
XYL Growth Ratios
| Growth Correlation 3m | 29.1% |
| Growth Correlation 12m | -62.4% |
| Growth Correlation 5y | 64.3% |
| CAGR 5y | 14.15% |
| CAGR/Max DD 5y | 0.30 |
| Sharpe Ratio 12m | 1.20 |
| Alpha | -17.12 |
| Beta | 1.081 |
| Volatility | 23.60% |
| Current Volume | 2648.3k |
| Average Volume 20d | 1634.3k |
As of April 04, 2025, the stock is trading at USD 119.05 with a total of 2,648,260 shares traded.
Over the past week, the price has changed by -3.31%, over one month by -8.27%, over three months by +2.99% and over the past year by -6.04%.
Partly, yes. Based on ValueRay Fundamental Analyses, Xylem (NYSE:XYL) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 51.15 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XYL as of April 2025 is 113.50. This means that XYL is currently overvalued and has a potential downside of -4.66%.
Xylem has received a consensus analysts rating of 4.05. Therefor, it is recommend to buy XYL.
- Strong Buy: 9
- Buy: 4
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, XYL Xylem will be worth about 128.4 in April 2026. The stock is currently trading at 119.05. This means that the stock has a potential upside of +7.82%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 146.1 | 22.7% |
| Analysts Target Price | 147 | 23.4% |
| ValueRay Target Price | 128.4 | 7.8% |